Nothing Special   »   [go: up one dir, main page]

Chen et al., 2023 - Google Patents

Phosphatidylserine: An overview on functionality, processing techniques, patents, and prospects

Chen et al., 2023

View HTML
Document ID
11031517541393234790
Author
Chen J
Li J
Xu H
Li J
Yuan Y
Xu X
Bi Y
Publication year
Publication venue
Grain & Oil Science and Technology

External Links

Snippet

Phosphatidylserine (PS) is the part of the cell structure in the body and has many beneficial functions especially in the brain-related aging diseases. Although daily foods can provide PS to human body, the amount is very limited due to its poverty in most foods. To overcome …
Continue reading at www.sciencedirect.com (HTML) (other versions)

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic, hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. cannabinols, methantheline
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A61K31/683—Diesters of a phosphorus acid with two hydroxy compounds, e.g. phosphatidylinositols
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/12—Ketones
    • A61K31/122—Ketones having the oxygen directly attached to a ring, e.g. quinones, vitamin K1, anthralin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/59—Compounds containing 9, 10- seco- cyclopenta[a]hydrophenanthrene ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; THEIR TREATMENT, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES
    • A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells

Similar Documents

Publication Publication Date Title
US8877239B2 (en) Lipid supplements for maintaining health and treatment of acute and chronic disorders
Castro-Gómez et al. Relevance of dietary glycerophospholipids and sphingolipids to human health
ES2875975T3 (en) Eicosapentaenoic Acid (EPA) Formulations
US20140134228A1 (en) Chewable wafers containing lipid supplements for maintaining health and the treatment of acute and chronic disorders
Mikołajczak Coconut oil in human diet-nutrition value and potential health benefits
US9717734B2 (en) Chewable lipid supplements containing caffeine for increasing alertness, focus and energy
AU2020283321A1 (en) Very long chain fatty acids for treatment and alleviation of diseases
Turunen et al. Blood concentration of coenzyme Q10 increases in rats when esterified forms are administered
Chen et al. Phosphatidylserine: An overview on functionality, processing techniques, patents, and prospects
Karuna et al. Vegetable oil-based nutraceuticals
AU2014202925B2 (en) Chewable wafers containing lipid supplements for maintaining health and the treatment of acute and chronic disorders
Sarma et al. Fortification methods of coenzyme Q10 in yogurt and its health functionality—a review
US11253531B2 (en) Lipid supplements for reducing nerve action potentials
de Azua et al. Fatty acid metabolism in liver and muscle is strongly modulated by photoperiod in Fischer 344 rats
Potter et al. Alternative treatments in pediatric bipolar disorder
Hussain et al. Phosphatidylserine: A comprehensive overview of synthesis, metabolism, and nutrition
Chen et al. Grain & Oil Science and Technology
US10874681B2 (en) Oral lipid supplements for treating pain and fibromyalgia
Hossen Enzyme catalyzed synthesis of structured phospholipids with conjugated linoleic acid and plant sterols
Liu et al. Phosphatidylserine: biology, technologies, and applications
Burri et al. Recent findings on cardiovascular and mental health effects of krill oil and omega-3 phospholipids
Wang et al. Alkylglycerol: not abundant but promising functional lipid
JP2023161714A (en) Brain function activation composition
Enemali et al. Effect of Monosodium Glutamate Orally Administered to Male Wister Rat on the Brain Lipid
Scholey et al. Functional foods and cognition